ALBRECHT DETLEF (Chief Medical Officer) sold 4.7% of their position (1K shares) of SATSUMA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $26.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+300.00
Price / share
$4.56
Trade value
$1.37K
% of position
Common Stock
Shares
−300.00
Price / share
$25.69
Trade value
$7.71K
% of position
Common Stock
Shares
+600.00
Price / share
$4.56
Trade value
$2.74K
% of position
Common Stock
Shares
−600.00
Price / share
$26.99
Trade value
$16.19K
% of position
Common Stock
Shares
+100.00
Price / share
$4.56
Trade value
$456.00
% of position
Common Stock
Shares
−100.00
Price / share
$27.81
Trade value
$2.78K
% of position
Net shares
+0.00
Net value
-$22.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2020 | M · Option Exercise | +300.00 | $4.56 | $1.37K | 1.5% | 20.21K | 20.51K |
| Common Stock Direct | 7/1/2020 | S · Sale | −300.00 | $25.69 | $7.71K | 1.5% | 20.51K | 20.21K |
| Common Stock Direct | 7/1/2020 | M · Option Exercise | +600.00 | $4.56 | $2.74K | 3.0% | 20.21K | 20.81K |
| Common Stock Direct | 7/1/2020 | S · Sale | −600.00 | $26.99 | $16.19K | 2.9% | 20.81K | 20.21K |
| Common Stock Direct | 7/1/2020 | M · Option Exercise | +100.00 | $4.56 | $456.00 | 0.5% | 20.21K | 20.31K |
| Common Stock Direct | 7/1/2020 | S · Sale | −100.00 | $27.81 | $2.78K | 0.5% | 20.31K | 20.21K |
| Total | +0.00 | -$22.12K | ||||||
Stock Option (Right to Buy)
Common Stock
1K shares
Shares
−1K
Strike price
4.56
Held after
69.47K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1K shares | 7/1/2020 | S · Sale | −1K | 4.56 | — | 69.47K |